Efficacy of PD-1 inhibition in recurrent Head and Neck cancer. A national prospective cohort study.

PD-1 inhibitors are well established in the treatment of recurrent or metastatic…" />

We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.